Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease (COPD) is associated with structural and functional changes in the pulmonary circulation that commence at an early stage. To investigate whether vascular endothelial growth factor (VEGF) might be implicated as a mediator in COPD-associated pulmonary vascular changes, we studied surgical specimens obtained from 19 nonsmokers, 21 smokers with normal lung function, 28 patients with moderate COPD, and 10 patients with severe emphysema. The expression of VEGF in pulmonary muscular arteries was evaluated by immunohistochemistry, its protein content in lung tissue by Western blot analysis, and VEGF mRNA and its isoforms were analyzed by reverse transcription-polymerase chain reaction. The immunohistochemical expression of VEGF was increased in pulmonary arteries of smokers (median, 68% [interquartile range, 60-88]) and patients with moderate COPD (77% [63-82]), compared with nonsmokers (53% [40-63]) (p < 0.05 each). The expression of VEGF in smooth muscle cells correlated with the thickness of the vessel wall (r = 0.38, p < 0.01). VEGF protein content in lung tissue was reduced in severe emphysema, where reverse transcription-polymerase chain reaction demonstrated a lower proportion of the VEGF189 isoform. In conclusion, the expression of VEGF varies according to the severity of COPD and might be involved in the pathogenesis of pulmonary vascular remodeling at early stages of the disease.

[1]  N. Tamura,et al.  Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. , 1998, Circulation.

[2]  C. Patterson,et al.  Induction of Vascular Endothelial Growth Factor Gene Expression by Interleukin-1 in Rat Aortic Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[3]  M. Dake,et al.  Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. , 2001, Journal of the American College of Cardiology.

[4]  D Ros,et al.  Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[5]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[6]  W. Thurlbeck,et al.  Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health Nocturnal Oxygen Therapy Trial , 2004, Lung.

[7]  Weidong Zhao,et al.  Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. , 2002, The American journal of pathology.

[8]  V. Peinado,et al.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[9]  A. Chaouat,et al.  "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[10]  A. Takeshita,et al.  Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. , 2000, Circulation.

[11]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[12]  M. Shibuya,et al.  Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis , 2002, Circulation.

[13]  A. Churg,et al.  Cigarette Smoke Induces Rapid Changes in Gene Expression in Pulmonary Arteries , 2002, Laboratory Investigation.

[14]  B. Zetter,et al.  Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. , 1999, Microvascular research.

[15]  W. Jiménez,et al.  Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis , 2001, Hepatology.

[16]  A. Ishida,et al.  Expression of vascular endothelial growth factor receptors in smooth muscle cells , 2001, Journal of cellular physiology.

[17]  Y. Omori,et al.  Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking. , 1998, Metabolism: clinical and experimental.

[18]  D. Tibboel,et al.  Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension , 1999, Thorax.

[19]  F. Sciurba,et al.  Lung volume reduction surgery for emphysema. , 1996, Chest.

[20]  V. Peinado,et al.  Endothelial dysfunction in pulmonary arteries of patients with mild COPD. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[21]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  V. Peinado,et al.  Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. , 2001, American journal of respiratory and critical care medicine.

[23]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[24]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[25]  M. Sunday,et al.  Differential expression of VEGF isoforms in mouse during development and in the adult , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[26]  M. Wilkinson,et al.  A pathophysiological study of 10 cases of hypoxic cor pulmonale. , 1988, The Quarterly journal of medicine.

[27]  J. Caro,et al.  Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[28]  G. Semenza,et al.  Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.

[29]  S. Eddahibi,et al.  Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. , 2000, American journal of respiratory cell and molecular biology.

[30]  M. Marrero,et al.  Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src* , 1999, The Journal of Biological Chemistry.

[31]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[32]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[33]  J. Keiser,et al.  Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. , 1998, Circulation research.

[34]  V. Peinado,et al.  Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD , 2002, European Respiratory Journal.

[35]  C. Galambos,et al.  Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. , 2002, American journal of respiratory cell and molecular biology.

[36]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[37]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[38]  Q. Hamid,et al.  Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. , 2001, The Journal of allergy and clinical immunology.